Enuresis Treatment Market: Introduction

  • Enuresis can be described as an intermittent urinary incontinence during sleep in children above the age of 5 years. According to an estimate by the American Academy of Family Physicians, over 5 million to 7 million children in the U.S. are suffering from enuresis.  
  • The pathophysiology of enuresis includes the inability to wake from sleep when the bladder is full, together with excessive nighttime urine production or a reduced functional capacity of the bladder. Enuresis is also associated with several conditions, such as diabetes mellitus, constipation, chronic kidney disease, obstructive sleep apnea, diabetes insipidus, and psychiatric disorders.
  • Enuresis is a common problem in childhood. According to different studies, around 7% boys and 3% girls aged 5 years develop enuresis. By the age of 10 years, the number drops to 3% in boys and 2% in girls.
  • Enuresis is also caused by certain medications that lead to confusion or changes in behavior as a side effect. If no physical cause is found, the doctor will base a diagnosis of enuresis on the child's symptoms and behavior.

Get an Idea about the Offerings of Our Enuresis Treatment Market Report from this Brochure

Key Drivers of Global Enuresis Treatment Market

  • Awareness about enuresis and its treatment and a large number of patient pool can be attributed to the expansion of the global enuresis treatment market. Bed wetting alarms usually for eight to twelve weeks are the mainstay of therapy for the management of enuresis.
  • The treatment of primary monosymptomatic enuresis (condition in which the only symptom is nocturnal bed-wetting) starts with counseling of the child and parents on effective behavioral modifications. First-line treatments for enuresis comprise desmopressin and bed alarm therapy.
  • The choice of treatment is based on the age of the child and nighttime voiding patterns. Referral to a pediatric urologist is indicated in case of primary enuresis that is refractory to standard therapies and enuresis that is associated with a few secondary causes such as neurologic disorders, recurrent urinary tract infection, and urinary tract malformation.

North America to Hold a Major Share of Global Enuresis Treatment Market

  • North America is expected to account for a major share of the global enuresis treatment market. High diagnosis rate, awareness among people about the management and treatment of enuresis, and a developed health care infrastructure are some of the factors responsible for the dominant share of the region. Europe is expected to follow North America, in terms of revenue. Favorable reimbursement scenario, developed health care infrastructure, and high disposable income are factors driving the enuresis treatment market in the region.
  • The enuresis treatment market in Asia Pacific is expected to grow at the maximum rate during the forecast period, owing to government interventions pertaining to allocation of funds for conducting research activities based on new therapies and treatment, developing health care infrastructure, and increasing baby boomer population in the region.  China and India are key markets in the Asia Pacific region.
  • The enuresis treatment market in Middle East & Africa is estimated to expand at a rapid pace during the forecast period due to rise in investments in the health care industry of the region

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Enuresis Treatment Market Report

Key Players Operating in Global Market

The global enuresis treatment market is highly competitive with key manufacturers adopting various strategies to gain market share. Some of the key players operating in the global enuresis treatment market are:

  • Ferring B.V.
  • Pfizer Inc.
  • Amring Pharmaceuticals Inc.
  • Novartis AG
  • CSL Limited
  • Sanofi S.A
  • Sun Pharmaceuticals Industries Ltd.

Global Enuresis Treatment Market: Research Scope

Global Enuresis Treatment Market, by Drug Class

  • Desmopressin
  • Anticholinergic Agents
  • Imipramine
  • Others

Global Enuresis Treatment Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Enuresis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.